Nasal Recombinant Hirudin-2 Delivery: Absorption and Its Mechanism in Vivo and in Vitro Studies
-
- Zhang Yujie
- Department of Chinese Pharmacy, P.O.B.3, Beijing University of Traditional Chinese Medicine
-
- Zhang Qiang
- School of Pharmaceutical Sciences, Health Science Center, Peking University
-
- Sun Yikun
- Department of Chinese Pharmacy, P.O.B.3, Beijing University of Traditional Chinese Medicine
-
- Sun Jianning
- Department of Chinese Pharmacy, P.O.B.3, Beijing University of Traditional Chinese Medicine
-
- Wang Xiaoliang
- Department of Chinese Pharmacy, P.O.B.3, Beijing University of Traditional Chinese Medicine
-
- Chen Mingxia
- Department of Chinese Pharmacy, P.O.B.3, Beijing University of Traditional Chinese Medicine
この論文をさがす
抄録
The objective of this study was to investigate the feasibility of systemic absorption of recombinant hirudin-2 (rHV2) by nasal delivery, and its possible absorption mechanism. The degradation of rHV2 in the nasal tissue homogenate and extracts of mucosae of rabbit, as well as the degradation inhibition of enzyme inhibitor (bacitracin) was evaluated. The bioavailability of rHV2 and the improvement with enhancers, after nasal administration in rats was investigated. For further understanding of the transport and uptake characteristics of rHV2, in vitro transport experiment under various conditions using diffusion chamber technique in excised rabbit nasal epithelium was performed. It was found that rHV2 underwent rapid degradation in rabbit nasal homogenate, but it was more stable in the extracts of nasal mucosae surface. Bacitracin was able to inhibit the degradation of rHV2 to certain extent. rHV2 was detected in the rat plasma by chromogenic substrate assay after nasal administration and some enhancers also significantly increased the nasal absorption of rHV2. The transport and uptake of rHV2 across nasal epithelium was concentration-dependent and unsaturated, and was significantly inhibited by low temperature, NaN3, DNP and colchicines, while was less affected by alteration of transport direction. These results demonstrate that the possible absorption mechanism of rHV2 by nasal mucosa appears to be associated with the endocytosis as well as passive diffusion process.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 28 (12), 2263-2267, 2005
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679601310336
-
- NII論文ID
- 110004049128
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 7720915
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可